5-methoxy-6-methyl-2-aminoindan has been researched along with 3,4-methylenedioxyamphetamine in 7 studies
Studies (5-methoxy-6-methyl-2-aminoindan) | Trials (5-methoxy-6-methyl-2-aminoindan) | Recent Studies (post-2010) (5-methoxy-6-methyl-2-aminoindan) | Studies (3,4-methylenedioxyamphetamine) | Trials (3,4-methylenedioxyamphetamine) | Recent Studies (post-2010) (3,4-methylenedioxyamphetamine) |
---|---|---|---|---|---|
13 | 0 | 0 | 4,806 | 77 | 1,373 |
Protein | Taxonomy | 5-methoxy-6-methyl-2-aminoindan (IC50) | 3,4-methylenedioxyamphetamine (IC50) |
---|---|---|---|
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.2314 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 2.7129 | |
Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.996 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 2.6486 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cozzi, NV; Marona-Lewicka, D; Monte, AP; Nichols, DE | 1 |
Kurrasch, D; Marona-Lewicka, D; Nichols, DE; Parker, MA; Shulgin, AT | 1 |
Frescas, SP; Johnson, MP; Nichols, DE; Oberlender, R | 1 |
Marona-Lewicka, D; Nichols, DE | 2 |
Huang, X; Nichols, DE | 1 |
Brownfield, MS; Levy, AD; Li, Q; Murakami, I; Nichols, DE; Stall, S; Van de Kar, LD | 1 |
7 other study(ies) available for 5-methoxy-6-methyl-2-aminoindan and 3,4-methylenedioxyamphetamine
Article | Year |
---|---|
Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methylenedioxy)amphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Benzofurans; Brain; Discrimination Learning; Dopamine; Indenes; Male; Molecular Structure; Norepinephrine; Rats; Rats, Sprague-Dawley; Serotonin; Structure-Activity Relationship; Synaptosomes; Tetrahydronaphthalenes | 1993 |
Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA).
Topics: 3,4-Methylenedioxyamphetamine; Animals; Antidepressive Agents; Behavior, Animal; Brain; Dioxoles; In Vitro Techniques; Male; Rats; Rats, Sprague-Dawley; Serotonin Agents; Synaptosomes | 1998 |
Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphenyl)-2-aminopropane and 5-methoxy-6-methyl-2-aminoindan: similarities to 3,4-(methylenedioxy)methamphetamine (MDMA).
Topics: 3,4-Methylenedioxyamphetamine; Animals; Behavior, Animal; Brain; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Indans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Phenethylamines; Rats; Rats, Inbred Strains; Serotonin Antagonists; Stereoisomerism; Structure-Activity Relationship | 1991 |
Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Behavior, Animal; Discrimination Learning; Dose-Response Relationship, Drug; Indans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Stereoisomerism | 1994 |
5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Hippocampus; Hydrazines; Indans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1993 |
Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAi) and p-methylthioamphetamine (MTA).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Fluoxetine; Indans; Male; Oxytocin; Prolactin; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Vasopressins | 1996 |
Drug discrimination studies of the interoceptive cues produced by selective serotonin uptake inhibitors and selective serotonin releasing agents.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Antidepressive Agents, Second-Generation; Citalopram; Conditioning, Operant; Discrimination, Psychological; Fluoxetine; Indans; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists | 1998 |